Coforge Gears Up for Q2 Reveal on 24th October; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q2 Results 

Coforge Q2 Results: Coforge, a bulk drug manufacturer serving various pharmaceutical companies, is all set to announce its Q2 results for FY26 on 24th October 2025. Financial analysts anticipate an increase in revenue due to higher sales and significant growth in PAT.

Coforge Q2 Results 2025 Preview

• Coforge’s revenue is expected to be in the range of ₹3,062.30 crore to ₹4,678.56 crore, marking a healthy 29.92% to 30.00% YoY increase. 
• Profit After Tax, or PAT, is projected to rise by 51.80% YoY or 34.67% QoQ. 
• EBITDA of Coforge is expected to decrease by 36.72% YoY to ₹3,567.00 crore.
• Gross profit is expected to increase by 21.20% (QoQ) and 25.80% (YoY).   

Coforge Share Performance 

• In the past six months, the share price of Coforge has risen by 37.51% to reach ₹1,762.50.
• Moreover, over the past year, the stock has risen by 22.32%.
• Despite this weak short-term performance, Coforge’s stock has delivered a financially sound return of 2.81% over the past 5 years.
• As of 16th October 2025, the stock traded at ₹1,762.60 per share, with a day high of ₹1,775.00. 

Key Factors to Watch for Coforge

• Coforge operates in a highly competitive market, facing pressure from both domestic and international brands.
• The company’s in-house manufacturing capabilities enable better quality control and strategic operations. 
• Coforge’s performance is mainly linked to the broader economic cycle, and high inflation can reduce demand for its products.   

Final Thoughts

Coforge will announce its Q2 FY26 results on 24th October, 2025. Analysts expect strong revenue growth of up to 29.92% YoY, a 51.80% rise in PAT, and a 51.08% increase in EBITDA. Coforge mainly focuses on the new products of this company and EBITDA growth. 

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Top 10 Penny Stocks in India | Penny Stocks to Buy in 2025

Best Stocks to Buy Today: Explore Best Stocks With Expected Trends

Milky Mist Dairy Foods IPO Details: Everything You Should Know about 

Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?

Taurian MPS IPO GMP & Review: Should You Apply or Avoid?

Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?

Dev Accelerator IPO GMP & Review: Apply or Avoid?

Vigor Plast India IPO Listing Preview: What to Expect Now?

Krupalu Metals IPO GMP: Day 3 IPO Live Updates